US2020282029A1PendingUtilityA1
Methods for treating osteoarthritis pain
Est. expirySep 12, 2034(~8.1 yrs left)· nominal 20-yr term from priority
A61K 38/4893A61P 29/02A61P 19/02A61P 25/04A61K 9/0019
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for alleviating osteoarthritis-associated symptoms by selecting a treatment-eligible patient and local administration of a clostridial derivative, such as a botulinum toxin, to an osteoarthritis-affected site are disclosed herein.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for treating or alleviating osteoarthritis (OA)-associated pain in a patient in need thereof, the method comprising locally administering a therapeutically effective amount of a clostridial derivative to an osteoarthritis-affected site of the OA patient, thereby treating or alleviating the osteoarthritis-associated pain in the patient,
wherein the therapeutically effective amount is from about 200 units to about 800 units, and wherein the clostridial derivative is a botulinum toxin type A.
2 . The method of claim 1 , wherein the osteoarthritis-affected site is selected from the group consisting of a knee joint, a hip joint, a hand joint, a shoulder joint, an ankle joint, a foot joint, an elbow joint, a wrist joint, a sacroiliac joint, a spine joint, and combinations thereof.
3 . The method of claim 1 , wherein the administering is by intra-articular injection into a joint space.
4 . The method of claim 1 , wherein the clostridial derivative is onabotulinumtoxinA.
5 . The method of claim 4 , wherein the therapeutically effective amount ranges from about 300 to about 500 units of onabotulinumtoxinA.
6 . The method of claim 5 , wherein the therapeutically effective amount is about 400 units.
7 . The method of claim 1 , wherein the clostridial derivative is incobotulinumtoxinA.
8 . The method of claim 7 , wherein the therapeutically effective amount ranges from about 300 to about 500 units of incobotulinumtoxinA.
9 . The method of claim 8 , wherein the therapeutically effective amount is about 400 units.
10 . The method of claim 1 , wherein the patient's pain is categorized as nociceptive.Join the waitlist — get patent alerts
Track US2020282029A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.